DADATA·ANALYSIS
FREE
company · cik 1326190

Altimmune, Inc.

ALTNasdaqSIC 2834public
financials · annual · usd2026
Revenue$4.4M
Net income-$88.1M
Total assets$279.9M
Total liabilities$55.0M
Equity$224.9M
LT debt$34.3M
Operating cash-$67.5M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts1